FTSE All-Share
4.983,02
PKT
+9,68
PKT
+0,19
%
Werbung
Analysen zu FTSE All-Share-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 29.10.12 | Tullow Oil hold | Société Générale Group S.A. (SG) | |
| 29.10.12 | Lloyds Banking Group kaufen | Die Actien-Börse | |
| 29.10.12 | Unilever underperform | Credit Suisse Group | |
| 29.10.12 | Anglo American neutral | Sarasin Research | |
| 29.10.12 | BT Group hold | Société Générale Group S.A. (SG) | |
| 29.10.12 | Smith Nephew sell | Société Générale Group S.A. (SG) | |
| 29.10.12 | Anglo American hold | Société Générale Group S.A. (SG) | |
| 29.10.12 | Vodafone Group buy | Goldman Sachs Group Inc. | |
| 29.10.12 | AstraZeneca underperform | Credit Suisse Group | |
| 26.10.12 | Rio Tinto outperform | Credit Suisse Group | |
| 26.10.12 | Rio Tinto buy | Société Générale Group S.A. (SG) | |
| 26.10.12 | Unilever neutral | Exane-BNP Paribas SA | |
| 26.10.12 | Anglo American buy | Deutsche Bank AG | |
| 26.10.12 | Imperial Brands underperform | Exane-BNP Paribas SA | |
| 26.10.12 | Pearson outperform | Exane-BNP Paribas SA | |
| 26.10.12 | AstraZeneca hold | Société Générale Group S.A. (SG) | |
| 26.10.12 | Anglo American sell | Société Générale Group S.A. (SG) | |
| 26.10.12 | Unilever halten | Independent Research GmbH | |
| 26.10.12 | Unilever sell | Société Générale Group S.A. (SG) | |
| 26.10.12 | Glencore neutral | Sarasin Research | |
| 26.10.12 | Unilever equal-weight | Morgan Stanley | |
| 26.10.12 | BP neutral | Goldman Sachs Group Inc. | |
| 26.10.12 | HSBC outperform | Credit Suisse Group | |
| 25.10.12 | Shell (ex Royal Dutch Shell) buy | Nomura | |
| 25.10.12 | Unilever neutral | Sarasin Research | |
| 25.10.12 | GSK underperform | Exane-BNP Paribas SA | |
| 25.10.12 | Vodafone Group underperform | Exane-BNP Paribas SA | |
| 25.10.12 | BP neutral | Citigroup Corp. | |
| 25.10.12 | BAT buy | Nomura | |
| 25.10.12 | Standard Chartered buy | Nomura | |
| 25.10.12 | Unilever hold | ING | |
| 25.10.12 | BAT equal-weight | Morgan Stanley | |
| 25.10.12 | BAT outperform | Exane-BNP Paribas SA | |
| 25.10.12 | Marks Spencer underperform | Exane-BNP Paribas SA | |
| 25.10.12 | BAT halten | Independent Research GmbH | |
| 25.10.12 | AstraZeneca neutral | Citigroup Corp. | |
| 25.10.12 | Anglo American neutral | Citigroup Corp. | |
| 25.10.12 | Standard Chartered buy | Citigroup Corp. | |
| 25.10.12 | BAT hold | Société Générale Group S.A. (SG) | |
| 25.10.12 | Barclays buy | Citigroup Corp. |